|
|
- IRMS - Nicolae Testemitanu SUMPh
- 1. COLECȚIA INSTITUȚIONALĂ
- MedEspera: International Medical Congress for Students and Young Doctors
- MedEspera 2026
Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12710/33922
| Title: | CALCIUM HYDROXIDE AS AN INTRACANAL MEDICATION IN CHRONIC GANGRENOUS PULPITIS |
| Authors: | Lungu, Alexandru |
| Keywords: | calcium hydroxide;endodontics;intracanal medication;root canal;infection;pulp necrosis;periapical healing |
| Issue Date: | 2026 |
| Publisher: | Centrul Editorial-Poligrafic Medicina |
| Citation: | Lungu, Alexandru. CALCIUM HYDROXIDE AS AN INTRACANAL MEDICATION IN CHRONIC GANGRENOUS PULPITIS. In: MedEspera 2026, p. 103. ISBN 978-9975-82-486-6. |
| Abstract: | Introduction. Endodontic infections represent a major cause of pulp necrosis and periapical pathology. In teeth with gangrenous pulp, the elimination of microorganisms from the root canal system is essential for successful treatment. Calcium hydroxide has long been used as an intracanal medicament due to its antimicrobial properties and ability to promote healing of periapical tissues. Aim of study. The aim of this narrative literature review is to evaluate the antimicrobial properties, biological effects, and clinical effectiveness of calcium hydroxide as an intracanal medication in the management of infected root canals associated with pulpal necrosis. Methods and materials. A narrative literature review was conducted using scientific publications indexed in international databases, including PubMed, Google Scholar, and ScienceDirect. A total of 18 relevant articles published between 2005 and 2023 were selected based on their relevance to the antimicrobial activity, biological properties, and clinical application of calcium hydroxide in endodontic treatment. The selected studies included review articles, experimental studies, and clinical investigations. Results. The reviewed studies demonstrate that calcium hydroxide presents significant antimicrobial activity due to its high pH (approximately 12.5), which disrupts bacterial cell membranes, denatures proteins, and inactivates bacterial enzymes. Several studies report that the use of calcium hydroxide as an intracanal medication can reduce bacterial counts within the root canal system by up to 91 -98% after one week of application. Clinical studies also indicate that treatment protocols including calcium hydroxide are associated with periapical healing rates ranging between 71.54% and 89.73% in teeth with necrotic pulp and apical periodontitis. Additionally, calcium hydroxide has been shown to neutralize bacterial endotoxins and stimulate mineralized tissue formation, contributing to the repair of periapical tissues. However, certain microorganisms, particularly Enterococcus faecalis, may demonstrate resistance to calcium hydroxide, which represents a limitation in some persistent infections. Conclusions. Calcium hydroxide remains one of the most effective and widely used intracanal medicaments in endodontic therapy. Its antimicrobial properties, biological compatibility, and ability to promote tissue healing make it a valuable component of root canal treatment. Nevertheless, further research is necessary to improve its effectiveness against resistant microorganisms and optimize clinical protocols. |
| metadata.dc.relation.ispartof: | MedEspera 2026. The 11th International Medical Congress for Students and Young Doctors, 6-8 May 2026 |
| URI: | https://medespera.md/documents/abstract-book-4.pdf https://repository.usmf.md/handle/20.500.12710/33922 |
| ISBN: | 978-9975-82-486-6 |
| Appears in Collections: | MedEspera 2026
|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|